Penumbra, Inc. PEN

PEN Company Overview

Penumbra, Inc. is a U.S.-based medical device company focused on developing and commercializing technologies for the diagnosis and treatment of vascular and neurological conditions. The company primarily operates in the interventional healthcare and medical technology industries, with a concentration on neurovascular and peripheral vascular therapies. Penumbra’s products are widely used in minimally invasive procedures intended to treat ischemic stroke, venous thromboembolism, pulmonary embolism, and other vascular disorders. The company also operates in healthcare immersive technologies through its rehabilitation and performance-focused digital products.

The company’s principal revenue drivers include thrombectomy systems, aspiration catheters, embolization devices, access systems, and associated consumables used in neuro and peripheral interventions. Key customer segments include hospitals, stroke centers, interventional radiologists, neurosurgeons, neurologists, and vascular specialists. Penumbra is recognized for its emphasis on aspiration-based thrombectomy technology and physician-focused device innovation. Founded in 2004 by Adam Elsesser, the company initially focused on stroke intervention technologies and expanded into broader vascular and thrombectomy markets through internal development and selective acquisitions. Over time, Penumbra broadened its portfolio into computer-assisted rehabilitation and immersive healthcare technologies.